Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
BACKGROUND: People with type 2 diabetes mellitus are at increased risk from cardiovascular disease. Dietary omega-3 polyunsaturated fatty acids (PUFAs) are known to reduce triglyceride levels, but their impact on cholesterol levels, glycemic control and vascular outcomes are not well known. OBJECTIV...
Κύριοι συγγραφείς: | Hartweg, J, Perera, R, Montori, V, Dinneen, S, Neil, H, Farmer, A |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2008
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
ανά: Hartweg, J, κ.ά.
Έκδοση: (2008) -
Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes.
ανά: Hartweg, J, κ.ά.
Έκδοση: (2007) -
Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes
ανά: Hartweg, J, κ.ά.
Έκδοση: (2007) -
Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.
ανά: Hartweg, J, κ.ά.
Έκδοση: (2007) -
Omega-3 Polyunsaturated Fatty Acids in Treatment of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus
ανά: Aisulu T. Mussagalieva, MD, PhD, κ.ά.
Έκδοση: (2012-03-01)